Shicheng Guo
Bluesky
@shihcheng.bsky.social
—Followers
—Following
0Posts Analyzed
Analyzed Posts (2)
Shicheng Guo
@shihcheng.bsky.socialAug 1, 2026
Combining endurance and resistance training in HFpEF patients over 12 months showed significant improvements in health outcomes. Key findings: reduced hospitalizations and enhanced quality of life. #HFpEF PMID:39747684, Nat Med 2025, @NatureMedicine
DisagreementView analysis
Shicheng Guo
@shihcheng.bsky.socialJul 30, 2026
Trial explores feasibility of VLCD in 19 women with endometrial cancer & obesity. 91% adherence, 5.5% weight loss, 0 severe adverse events in 21-28 days. Thumbs up for VLCD! PMID:42192131, Nat Commun 2026, @NatureComms https://doi.org/10.1038/s41467-026-73519-w #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Very strongView analysis